Sri Ghatta

Sri Ghatta is a seasoned professional in clinical development, currently serving as Senior Director and Clinical Development Team Lead at Allogene Therapeutics since January 2022. Previously, Sri held the position of Director - Clinical Scientist at Genmab from September 2017 to January 2022, and served as Clinical Scientific Leader with a focus on Immuno-Oncology at GSK from April 2006 to September 2017. Sri possesses extensive expertise in developing and implementing strategies involving pharmacodynamic and predictive biomarkers, managing operational aspects of translational medicine, and overseeing clinical studies. Academic credentials include a PhD in Pharmacology from North Dakota State University, a Master's in Clinical Research Organization and Management from Drexel University, and a Master's in Pharmacology & Toxicology from the National Institute of Pharmaceutical Education and Research.